🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and tolerance of the combination of adefovir dipivox...
Status
Completed
Location
Phoenix Body Positive
Start Date
TBD
Trial ID
NCT00002184
Treatments Being Tested
An open study to Evaluate the Efficacy, Safety and Sustained effect of Clev...
Status
Terminated
Location
Samsung Medical Center
Start Date
2009-09
Trial ID
NCT01264133
Treatments Being Tested
The purpose of this study is to see if it is safe and effective to give ade...
Status
Completed
Location
Anderson Clinical Research
Start Date
TBD
Trial ID
NCT00002206
Treatments Being Tested
This 48-week open-label study of local manufactured adefovir dipivoxil Tabl...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12
Trial ID
NCT00441974
Treatments Being Tested
A double-blind randomized, parallel, multicenter with 48 weeks of treatment...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2008-02
Trial ID
NCT00641082
Treatments Being Tested
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in...
Status
Unknown
Location
The Fourth Affiliated Hospital of Haerbin Medical University
Start Date
2009-08
Trial ID
NCT00960518
Control of hepatitis B virus (HBV) infection can be difficult in HIV infect...
Status
Completed
Location
UC Davis Medical Center
Start Date
TBD
Trial ID
NCT00033163
Treatments Being Tested
To study the safety, tolerance, single and multiple dose pharmacokinetics, ...
Status
Completed
Location
Johns Hopkins Univ
Start Date
TBD
Trial ID
NCT00002346
Treatments Being Tested
The purpose of this study is to support the clinical value of entecavir by ...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01155427
This is a multi-centre, double blind, double dummy, randomised, controlled ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-03-30
Trial ID
NCT01300234
Treatments Being Tested